Hersh David S, Eisenberg Howard M
Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.
Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA -
J Neurosurg Sci. 2018 Apr;62(2):203-213. doi: 10.23736/S0390-5616.17.04230-8. Epub 2017 Nov 3.
Focused ultrasound (FUS) produces a region of high intensity at the focal zone of the beam but with minimal effects at adjacent areas, allowing the sonication of deep targets throughout the body. Despite early obstacles to transmitting ultrasound energy through the skull, recent advances in ultrasound technology, software, and real-time monitoring have resulted in a renewed interest in the clinical applications of transcranial FUS. Following extensive pre-clinical studies, ultrasound-induced thermal ablation has been approved by several countries for the treatment of essential tremor, Parkinson's disease, obsessive-compulsive disorder, depression, and neuropathic pain. Ongoing clinical trials involving patients with brain tumors, Alzheimer's disease, or epilepsy, and pre-clinical work involving stroke and hydrocephalus have the potential to significantly expand the possible indications for transcranial FUS in the future.
聚焦超声(FUS)在波束的焦点区域产生高强度区域,但对相邻区域的影响最小,从而能够对全身深处的目标进行超声处理。尽管早期在通过颅骨传输超声能量方面存在障碍,但超声技术、软件和实时监测方面的最新进展已使人们对经颅FUS的临床应用重新产生兴趣。经过广泛的临床前研究,超声诱导热消融已被多个国家批准用于治疗特发性震颤、帕金森病、强迫症、抑郁症和神经性疼痛。目前涉及脑肿瘤、阿尔茨海默病或癫痫患者的临床试验,以及涉及中风和脑积水的临床前研究,有可能在未来显著扩大经颅FUS的可能适应症。